
iRhythm Technologies IRTC
$ 118.02
-0.1%
Annual report 2025
added 02-19-2026
Country |
|
IPO year |
2016 |
Industry |
Medical instruments |
Stock Exchange |
NASDAQ GLOBALSPB |
Shares |
32 M |
Market Cap[1] |
$ 3.78 B |
EBITDA (LTM) |
$ -104 M |
P/E (LTM) |
-33.37 |
P/S (LTM) |
5.9 |
EPS (LTM) |
-3.54 |
Other stocks of industry "Medical instruments"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Harvard Bioscience
HBIO
|
$ 5.1 | -4.49 % | $ 226 M | Nasdaq Global Market | ||
|
Repro Med Systems
KRMD
|
$ 4.33 | -2.37 % | $ 200 M | Nasdaq Capital Market | ||
|
ICU Medical
ICUI
|
$ 129.02 | -0.7 % | $ 3.18 B | Nasdaq Global Select Market,SPB | ||
|
Luminex Corporation
LMNX
|
- | - | $ 1.75 B | Nasdaq Global Select Market | ||
|
Akers Biosciences, Inc.
AKER
|
- | -9.52 % | $ 20.6 M | Nasdaq Capital Market | ||
|
Atrion Corporation
ATRI
|
- | - | $ 810 M | Nasdaq Global Select Market,SPB | ||
|
Envista Holdings Corporation
NVST
|
$ 26.02 | 0.74 % | $ 4.37 B | NYSE | ||
|
LeMaitre Vascular
LMAT
|
$ 109.69 | 1.7 % | $ 2.48 B | Nasdaq Global Market,SPB | ||
|
Ekso Bionics Holdings
EKSO
|
$ 10.61 | 0.09 % | $ 25.7 M | Nasdaq Capital Market | ||
|
Masimo Corporation
MASI
|
$ 178.5 | 0.03 % | $ 9.51 B | Nasdaq Global Select Market,SPB | ||
|
Antares Pharma, Inc.
ATRS
|
- | - | $ 955 M | Nasdaq Capital Market | ||
|
Cantel Medical Corp.
CMD
|
- | -1.18 % | $ 3.4 B | NYSE | ||
|
CRH Medical Corporation
CRHM
|
- | - | $ 282 M | NYSE American | ||
|
Merit Medical Systems
MMSI
|
$ 67.86 | -0.39 % | $ 4.01 B | Nasdaq Global Select Market,SPB | ||
|
Hill-Rom Holdings, Inc.
HRC
|
- | -0.05 % | $ 10.3 B | NYSE,SPB | ||
|
Varian Medical Systems, Inc.
VAR
|
- | -0.02 % | $ 16.3 B | NYSE | ||
|
Nephros
NEPH
|
$ 3.02 | -2.89 % | $ 31.4 M | Nasdaq Global Select Market | ||
|
Haemonetics Corporation
HAE
|
$ 57.23 | -2.12 % | $ 2.88 B | NYSE,SPB | ||
|
Baxter International
BAX
|
$ 16.64 | 0.15 % | $ 8.54 B | NYSE,SPB | ||
|
OraSure Technologies
OSUR
|
$ 3.13 | 1.46 % | $ 230 M | Nasdaq Global Select Market,SPB | ||
|
Isoray
ISR
|
- | 0.03 % | $ 108 M | NYSE American | ||
|
AngioDynamics
ANGO
|
$ 10.45 | -2.43 % | $ 427 M | Nasdaq Global Select Market | ||
|
Intuitive Surgical
ISRG
|
$ 469.14 | -1.86 % | $ 167 B | Nasdaq Global Select Market,SPB | ||
|
AtriCure
ATRC
|
$ 29.48 | -1.01 % | $ 1.41 B | Nasdaq Global Market,SPB | ||
|
Pro-Dex
PDEX
|
$ 49.65 | 3.55 % | $ 163 M | Nasdaq Global Select Market | ||
|
InfuSystem Holdings
INFU
|
$ 9.6 | 0.05 % | $ 198 M | NYSE American | ||
|
Pulse Biosciences
PLSE
|
$ 21.22 | 1.36 % | $ 1.43 B | Nasdaq Global Select Market | ||
|
BioLife Solutions
BLFS
|
$ 19.61 | 2.3 % | $ 903 M | Nasdaq Global Select Market | ||
|
Milestone Scientific
MLSS
|
$ 0.29 | 2.44 % | $ 23.1 M | NYSE American | ||
|
Repligen Corporation
RGEN
|
$ 116.33 | -0.02 % | $ 6.48 M | Nasdaq Global Select Market,SPB | ||
|
electroCore
ECOR
|
$ 6.17 | 0.65 % | $ 52.3 K | Nasdaq Global Select Market | ||
|
The Cooper Companies
COO
|
$ 70.22 | -0.03 % | $ 14 B | NYSE,SPB | ||
|
STERIS plc
STE
|
$ 223.63 | 1.17 % | $ 22 B | NYSE,SPB | ||
|
Stereotaxis
STXS
|
$ 1.76 | -4.35 % | $ 160 M | NYSE American | ||
|
Predictive Oncology
POAI
|
- | - | $ 31.1 M | Nasdaq Capital Market | ||
|
Teleflex Incorporated
TFX
|
$ 106.54 | 0.54 % | $ 4.75 B | NYSE,SPB | ||
|
Glaukos Corporation
GKOS
|
$ 105.6 | -1.15 % | $ 5.11 B | NYSE,SPB | ||
|
ResMed
RMD
|
$ 229.38 | 0.59 % | $ 33.5 B | NYSE,SPB | ||
|
Utah Medical Products
UTMD
|
$ 64.34 | -1.21 % | $ 233 M | Nasdaq Global Select Market | ||
|
Microbot Medical
MBOT
|
$ 2.47 | -1.93 % | $ 25.2 M | Nasdaq Global Select Market | ||
|
Retractable Technologies
RVP
|
$ 0.73 | 0.69 % | $ 21.9 M | NYSE American | ||
|
NeuroMetrix
NURO
|
- | 5.05 % | $ 9.02 M | Nasdaq Global Select Market | ||
|
West Pharmaceutical Services
WST
|
$ 245.83 | 1.75 % | $ 17.8 B | NYSE,SPB | ||
|
STAAR Surgical Company
STAA
|
$ 19.02 | 2.76 % | $ 943 M | Nasdaq Global Market,SPB | ||
|
DENTSPLY SIRONA
XRAY
|
$ 11.63 | 0.74 % | $ 2.32 B | Nasdaq Global Select Market,SPB | ||
|
Becton, Dickinson and Company
BDX
|
$ 155.78 | -0.28 % | $ 44.8 B | NYSE,SPB | ||
|
Alcon
ALC
|
$ 74.14 | 0.03 % | $ 40.4 B | NYSE |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.